VESELKA, Josef, David ZEMÁNEK, Denisa JAHNLOVÁ, Jan KREJČÍ, Jaroslav JANUŠKA, Maciej DABROWSKI, Thomas BARTEL a Pavol TOMAŠOV. Risk and Causes of Death in Patients After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. Canadian Journal of Cardiology. New York: Elsevier Science Ltd., roč. 31, č. 10, s. 1245-1251. ISSN 0828-282X. doi:10.1016/j.cjca.2015.02.010. 2015.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Risk and Causes of Death in Patients After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
Autoři VESELKA, Josef (203 Česká republika), David ZEMÁNEK (203 Česká republika), Denisa JAHNLOVÁ (203 Česká republika), Jan KREJČÍ (203 Česká republika, garant, domácí), Jaroslav JANUŠKA (203 Česká republika), Maciej DABROWSKI (616 Polsko), Thomas BARTEL (784 Spojené arabské emiráty) a Pavol TOMAŠOV (203 Česká republika).
Vydání Canadian Journal of Cardiology, New York, Elsevier Science Ltd. 2015, 0828-282X.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 3.112
Kód RIV RIV/00216224:14110/15:00085299
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.cjca.2015.02.010
UT WoS 000365242300008
Klíčová slova anglicky SUDDEN CARDIAC DEATH; LONG-TERM SURVIVAL; TASK-FORCE; MULTICENTER; PREVENTION; GUIDELINES; EXPERIENCE; DIAGNOSIS; MYECTOMY; THERAPY
Štítky EL OK
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 17. 12. 2015 11:34.
Anotace
Background: Because the final myocardial scar might be theoretically associated with an increased risk of sudden cardiac death, the longterm clinical course of patients who undergo alcohol septal ablation (ASA) is still a matter of debate. In this retrospective multicentre study, we report outcomes after ASA, including survival, analysis of causes of deaths, and association between time and cause of death. Methods: We enrolled 366 consecutive patients (58 +/- 12 years, 54% women) who were treated using ASA and followed-up for 5.1 +/- 4.5 years. Results: The in-hospital and 30-day mortality were 0.5% and 0.8%, respectively; the ASA-related morbidity was < 20%. Overall, 52 patients died during 1867 patient-years, which means the all-cause mortality rate was 2.8% per year. The mortality rates of sudden death and sudden death with an appropriate implantable cardioverterdefibrillator (ICD) discharge were 0.4% and 1% per year, respectively. Patients with sudden death or appropriate ICD discharge experienced these mortality events at younger age than patients who died of other hypertrophic obstructive cardiomyopathy-related causes (60.8 years [range, 52-71.5 years] vs 72.4 years [range, 64.2-75.2 years]; P = 0.048). A total of 292 patients (80%) had an outflow gradient <= 30 mm Hg, and 327 patients (89%) were in New York Heart Association class <= II at the last clinical check-up. Conclusions: ASA had low procedure-related mortality, with subsequent 1% occurrence of sudden mortality events per year and 2.8% mortality rate per year in the long-term follow-up. Patients with sudden death or ICD discharge experienced the mortality events approximately 1 decade earlier than patients who died from other causes not related to hypertrophic cardiomyopathy.
VytisknoutZobrazeno: 19. 4. 2024 20:11